发布求助
文献互助 智能选刊 最新文献

Section 3: Production and Compounding最新文献

筛选
英文 中文
3PC-038 Autologous serum eye drops preparation: approach to the filtration step impact on the concentration of active molecules 3PC-038 自体血清滴眼液的制备：过滤步骤对活性分子浓度的影响
Section 3: Production and Compounding Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.95
P. Moncassin, M. Colin, E. Bernikier, J. Jost, S. Hantz, M. Rocher, PA Faye, V. Ratsimbazafy
{"title":"3PC-038 Autologous serum eye drops preparation: approach to the filtration step impact on the concentration of active molecules","authors":"P. Moncassin, M. Colin, E. Bernikier, J. Jost, S. Hantz, M. Rocher, PA Faye, V. Ratsimbazafy","doi":"10.1136/ejhpharm-2024-eahp.95","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.95","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"88 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140278299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-010 Development of a stable parenteral solution of topiramate for emergency treatment of status epilepticus 3PC-010 开发用于紧急治疗癫痫状态的托吡酯稳定肠外溶液
Section 3: Production and Compounding Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.67
S. Werner, N. Ott, S. Deuster
{"title":"3PC-010 Development of a stable parenteral solution of topiramate for emergency treatment of status epilepticus","authors":"S. Werner, N. Ott, S. Deuster","doi":"10.1136/ejhpharm-2024-eahp.67","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.67","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"8 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140268405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-007 Containment performance assessment of Chemfort® (Onguard®2) closed system transfer device according to 2016 draft NIOSH protocol at first and tenth activations end of shelf life 3PC-007 根据 2016 年 NIOSH 协议草案，对 Chemfort® (Onguard®2) 封闭系统转移装置在保质期结束时的第一次和第十次启动进行密封性能评估
Section 3: Production and Compounding Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.64
A. Wilkinson, L. Ozolina, K. Walker, M. Allwood, A. Wallace, R. Bon
{"title":"3PC-007 Containment performance assessment of Chemfort® (Onguard®2) closed system transfer device according to 2016 draft NIOSH protocol at first and tenth activations end of shelf life","authors":"A. Wilkinson, L. Ozolina, K. Walker, M. Allwood, A. Wallace, R. Bon","doi":"10.1136/ejhpharm-2024-eahp.64","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.64","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"201 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140270889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-033 Kiro Isolator®: a new, reliable, robotic device for the compounding of injectable anticancer drugs 3PC-033 Kiro Isolator®：用于配制注射用抗癌药物的新型、可靠的机器人设备
Section 3: Production and Compounding Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.90
B. Quitté, C. Cros, L. Escalup, J. Fouque, K. Rezai, S. Huguet, O. Madar, R. Desmaris, A. Hurgon, A. Acramel
{"title":"3PC-033 Kiro Isolator®: a new, reliable, robotic device for the compounding of injectable anticancer drugs","authors":"B. Quitté, C. Cros, L. Escalup, J. Fouque, K. Rezai, S. Huguet, O. Madar, R. Desmaris, A. Hurgon, A. Acramel","doi":"10.1136/ejhpharm-2024-eahp.90","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.90","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"55 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140272769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-021 Formulation of voriconazole ovules and efficacy in vulvovaginal Ccandidiasis by candida glabrata: a case report 3PC-021 伏立康唑胶囊的配方及其对念珠菌性外阴阴道炎的疗效：病例报告
Section 3: Production and Compounding Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.78
A. López Gómez, L. Rodríguez-De Francisco, C. Carrascal-Mozo, S. Lora-Escobar, P. Suárez Casillas, E. Hevia-Álvarez, JP Quintero-García, MJ Rodríguez-Hernández
{"title":"3PC-021 Formulation of voriconazole ovules and efficacy in vulvovaginal Ccandidiasis by candida glabrata: a case report","authors":"A. López Gómez, L. Rodríguez-De Francisco, C. Carrascal-Mozo, S. Lora-Escobar, P. Suárez Casillas, E. Hevia-Álvarez, JP Quintero-García, MJ Rodríguez-Hernández","doi":"10.1136/ejhpharm-2024-eahp.78","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.78","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"131 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140276353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-023 New activities within a clinical trial management unit: what new risks for the staff? 3PC-023 临床试验管理部门的新活动：员工面临哪些新风险？
Section 3: Production and Compounding Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.80
A. Boutin, B. Petitjean, F. Foursac, M. Antignac, F. Chabonnier Beaupel, C. Metz
{"title":"3PC-023 New activities within a clinical trial management unit: what new risks for the staff?","authors":"A. Boutin, B. Petitjean, F. Foursac, M. Antignac, F. Chabonnier Beaupel, C. Metz","doi":"10.1136/ejhpharm-2024-eahp.80","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.80","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"320 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140280540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-031 Usability of semi-solid extrusion 3D printing in hospital pharmacy settings to produce personalised oral medications for paediatric patients 3PC-031 在医院药房环境中使用半固态挤压 3D 打印为儿科患者生产个性化口服药物的可用性
Section 3: Production and Compounding Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.88
M. Rautamo, HM Tolonen, N. Asinger, H. Ruutiainen, S. Kuitunen, S. Kälvemark Sporrong, M. Sivén, M. Paulsson
{"title":"3PC-031 Usability of semi-solid extrusion 3D printing in hospital pharmacy settings to produce personalised oral medications for paediatric patients","authors":"M. Rautamo, HM Tolonen, N. Asinger, H. Ruutiainen, S. Kuitunen, S. Kälvemark Sporrong, M. Sivén, M. Paulsson","doi":"10.1136/ejhpharm-2024-eahp.88","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.88","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"1130 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140273014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-002 Stability of tenecteplase syringes after fractionation 3PC-002 替奈普酶注射器分馏后的稳定性
Section 3: Production and Compounding Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.59
M. Gómez Sánchez, R. Gazquez Perez, FD Fernandez Gines, M. Sánchez Valera, D. Gámez Torres, MG Díaz López
{"title":"3PC-002 Stability of tenecteplase syringes after fractionation","authors":"M. Gómez Sánchez, R. Gazquez Perez, FD Fernandez Gines, M. Sánchez Valera, D. Gámez Torres, MG Díaz López","doi":"10.1136/ejhpharm-2024-eahp.59","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.59","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"42 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140274503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-016 Physicochemical stability of moxifloxacin 1 mg/0.2 ml syringes for intracameral administration 3PC-016 用于鞘内注射的莫西沙星 1 毫克/0.2 毫升注射器的理化稳定性
Section 3: Production and Compounding Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.73
S. Heinz, ÁM Yuste, P. Villacorta, S. García, JJ Duque, P. Granda, I. Villabona, M. Sánchez De Castro, P. Prats, A. Correa, MH Gonzalo
{"title":"3PC-016 Physicochemical stability of moxifloxacin 1 mg/0.2 ml syringes for intracameral administration","authors":"S. Heinz, ÁM Yuste, P. Villacorta, S. García, JJ Duque, P. Granda, I. Villabona, M. Sánchez De Castro, P. Prats, A. Correa, MH Gonzalo","doi":"10.1136/ejhpharm-2024-eahp.73","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.73","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"94 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140278109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-009 The effect of accelerated light (stress) and natural sunlight exposures on cetuximab (Erbitux®): evaluation of aggregate formation and functionality 3PC-009 加速光照（应力）和自然日光照射对西妥昔单抗（Erbitux®）的影响：聚合体形成和功能性评估
Section 3: Production and Compounding Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.66
A. Torres-García, A. Torrente-López, J. Hermosilla, A. Aguilera-Ortega, J. Cabeza, A. Salmerón-García, N. Navas
{"title":"3PC-009 The effect of accelerated light (stress) and natural sunlight exposures on cetuximab (Erbitux®): evaluation of aggregate formation and functionality","authors":"A. Torres-García, A. Torrente-López, J. Hermosilla, A. Aguilera-Ortega, J. Cabeza, A. Salmerón-García, N. Navas","doi":"10.1136/ejhpharm-2024-eahp.66","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.66","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"48 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140279252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信